Heart Disease News and Research

Latest Heart Disease News and Research

Study: Patients may face radioactive risk from imaging tests

"At least four million Americans under age 65 are exposed to high doses of radiation each year from medical imaging tests, according to a new study in The New England Journal of Medicine," The New York Times reports. And about ten percent of those patients "receive very high doses, more than the maximum annual exposure allowed for nuclear power plant employees or anyone else who works with radioactive material." The study was based on a survey of nearly one million patients insured by UnitedHealthcare.

27 Aug 2009

Canadian Anesthesiologists' Society responds to reports on Michael Jackson's death

The Canadian Anesthesiologists' Society (CAS) represents the only trained physicians providing anesthetic services in Canada. CAS is responding to reports that Michael Jackson was given a fatal combination of drugs, including the powerful anesthetic propofol, prior to his death on June 25.

27 Aug 2009

Cumberland Pharmaceuticals posts $9.8 million revenues for the three months ended June 30, 2009

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on the hospital acute care and gastroenterology markets, today announced second quarter 2009 financial results.

27 Aug 2009

FBN features Prescient Medical's CEO

Prescient Medical Inc. announced that CEO Patricia Scheller, appeared on FOX Business Network (FBN) to discuss the company's groundbreaking products and recent achievement of CE Mark approval for their vProtect(TM) Luminal Shield Stent System.

27 Aug 2009

Geron provides additional comments on the recent clinical hold of Spinal Cord Injury IND

Geron Corporation today provided additional comments on the recent clinical hold on its Spinal Cord Injury IND.

27 Aug 2009

Contract research organization signs agreement to utilize NewCardio's QTinno(TM) software suite

NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that a top-three contract research organization has signed a Master Services Agreement (MSA) to use NewCardio's QTinno(TM) software suite as its technology in fully automated Thorough QT (TQT) and Phase 1 studies delivered by its centralized ECG core lab.

27 Aug 2009

Four medical groups of Resurrection Health Care Preferred earn nine blue stars in the 2009 Blue Star Report

Three out of four medical groups of Resurrection Health Care Preferred (RHCP) have earned nine blue stars, a perfect score, in the 2009 Blue Star Report -- an annual ranking of doctors in medical groups from Blue Cross Blue Shield of Illinois.

27 Aug 2009

FDA approves clinical study of ATS 3f(R) Aortic Bioprosthesis with the younger aortic valve replacement population

ATS Medical, Inc. manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced today that the FDA has approved a landmark clinical study in which cardiac surgeons will implant the ATS 3f(R) Aortic Bioprosthesis in a younger aortic valve replacement patient population that has not been previously studied in a controlled and scientific manner.

27 Aug 2009

Adventist Medical Center receives the Community Value Index Five-Star hospital award

Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC’s dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.

27 Aug 2009

Bioreference Laboratories to issue earnings results for Q3 Fiscal Year 2009

BioReference Laboratories, Inc. announced today it plans to issue earnings results for the third quarter of fiscal 2009 before the open of market trading on Wednesday, September 2, 2009.

27 Aug 2009

Haber’s Electromolecular Propulsion technology offers high molecular separation speeds

Haber, Inc. (“Haber”), (OTC: HABE), a Delaware corporation headquartered in Arlington, Mass., with proprietary technologies in the separations sciences and environmentally friendly processing of gold bearing ores, announced today that it has formed a wholly owned subsidiary incorporated in Delaware called “EMP Diagnostics Inc.” (“EDI”). The business of the new company will focus on the application of Haber’s Electromolecular Propulsion technology (EMP). EMP is a separation technology that achieves unrivaled molecular separation speeds and has other unique capabilities not attainable with electrophoresis or liquid chromatography.

27 Aug 2009

Beta-blockers are less effective at preventing stroke in older people with high blood pressure

A University of Leicester-led study may have uncovered the reason why Beta-blockers are less effective at preventing stroke in older people with high blood pressure, when compared to other drugs for high blood pressure.

27 Aug 2009

Urgent requirement for O negative blood group in Memorial Blood Centers

The need for blood never takes a vacation. Every two seconds, someone in our community needs blood. From premature infants to an organ transplant recipient who will typically require 40 units of blood to survive. And right now, the need is urgent. We are currently facing a shortage of Type 0 negative, the universal blood type that can be given to save the life of anyone, from premature infants and children having heart surgery to an organ transplant recipient who will typically require 40 units of blood to survive. Type B negative blood also is urgently needed.

27 Aug 2009

Study reveals that asthma patients fare better by taking oral controllers than inhaled corticosteroids

Mayo Clinic Proceedings published a peer-reviewed comparative effectiveness study performed by HealthCore, Inc. in its August edition. The study demonstrated that asthma patients in general had better clinical outcomes with oral controllers than inhaled corticosteroids.

27 Aug 2009

Spacelabs Healthcare launches Ultrasonic Cardiac Output Monitor in international markets

Spacelabs Healthcare today announced the launch of the Ultrasonic Cardiac Output Monitor (USCOM) in several new geographies, including Latin America, Africa, Europe, Australia and Middle East. USCOM’s unique and totally non-invasive method of cardiac monitoring provides an accurate, safe and efficient way of measuring how well the heart is functioning.

27 Aug 2009

New genetic mechanism to control body's fat-building process identified

At a time of alarming increases in obesity and associated diseases -- and fiery debates about the cost of health care -- a UCF research team has identified a new genetic mechanism that controls the body's fat-building process.

27 Aug 2009

European Medicines Agency accepts reviewal of Merck's MAA for regulatory approval of vernakalant IV

Merck & Co., Inc., Whitehouse Station, NJ, USA, which operates in many countries as Merck Sharp & Dohme Limited, announced today that the European Medicines Agency (EMEA) accepted for review the Company’s Marketing Authorisation Application (MAA) for regulatory approval of vernakalant intravenous (IV).

27 Aug 2009

Kudzu vine root extracts may be developed as a dietary supplement for people with metabolic syndrome

Kudzu, the nuisance vine that has overgrown almost 10 million acres in the southeastern United States, may sprout into a dietary supplement.

27 Aug 2009

CardioMEMS raises $22.1M to fund clinical trial of its heart failure pressure measurement system

CardioMEMS, Inc., a medical technology company that has developed and is commercializing proprietary wireless sensing and communication technology for the human body, today announced the completion of a $22.1M financing. The financing provides the company with additional capital to fund the company's CHAMPION clinical trial.

27 Aug 2009

Polycystic ovary syndrome in women can be relieved by acupuncture and exercise

Polycystic ovary syndrome, a common condition among women, can be relieved by the use of acupuncture and exercise. This has been shown by a recent study at the Sahlgrenska Academy, University of Gothenburg, Sweden.

27 Aug 2009

Heart Disease News and Research

Latest Heart Disease News and Research

Study: Patients may face radioactive risk from imaging tests

Canadian Anesthesiologists' Society responds to reports on Michael Jackson's death

Cumberland Pharmaceuticals posts $9.8 million revenues for the three months ended June 30, 2009

FBN features Prescient Medical's CEO

Geron provides additional comments on the recent clinical hold of Spinal Cord Injury IND

Contract research organization signs agreement to utilize NewCardio's QTinno(TM) software suite

Four medical groups of Resurrection Health Care Preferred earn nine blue stars in the 2009 Blue Star Report

FDA approves clinical study of ATS 3f(R) Aortic Bioprosthesis with the younger aortic valve replacement population

Adventist Medical Center receives the Community Value Index Five-Star hospital award

Bioreference Laboratories to issue earnings results for Q3 Fiscal Year 2009

Haber’s Electromolecular Propulsion technology offers high molecular separation speeds

Beta-blockers are less effective at preventing stroke in older people with high blood pressure

Urgent requirement for O negative blood group in Memorial Blood Centers

Study reveals that asthma patients fare better by taking oral controllers than inhaled corticosteroids

Spacelabs Healthcare launches Ultrasonic Cardiac Output Monitor in international markets

New genetic mechanism to control body's fat-building process identified

European Medicines Agency accepts reviewal of Merck's MAA for regulatory approval of vernakalant IV

Kudzu vine root extracts may be developed as a dietary supplement for people with metabolic syndrome

CardioMEMS raises $22.1M to fund clinical trial of its heart failure pressure measurement system

Polycystic ovary syndrome in women can be relieved by acupuncture and exercise

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Heart Disease News and Research

Latest Heart Disease News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in